Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Tumor Biology

• Publication date

  2013-05-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-013-0842-8PMID 23681802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.

  2012cited by this paper
• Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1

  2012cited by this paper
• Structural basis for matrix metalloproteinase 1-catalyzed collagenolysis.

  2012cited by this paper
• Regulation of matrix metalloproteinase activity in health and disease

  2011influential reference
• Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

  2011cited by this paper
• Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab

  2011cited by this paper
• Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy

  2011cited by this paper
• Matrix metalloproteinase-9 is a prognostic marker to predict survival of patients who underwent surgery due to rectal carcinoma.

  2011cited by this paper
• MMP-7 as a prognostic marker in colorectal cancer

  2011cited by this paper
• Tissue inhibitors of metalloproteinases

  2011cited by this paper
• Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer

  2011cited by this paper
• Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer

  2011cited by this paper
• Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.

  2011cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010cited by this paper
• Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer

  2010cited by this paper
• The clinical implications of MMP-11 and CK-20 expression in human breast cancer.

  2010cited by this paper
• Gelatin In Situ Zymography on Fixed, Paraffin-embedded Tissue: Zinc and Ethanol Fixation Preserve Enzyme Activity

  2010cited by this paper
• Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.

  2010cited by this paper
• Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy.

  2010cited by this paper
• MMP-9 (Gelatinase B) Expression is Associated With Disease-Free Survival and Disease-Specific Survival in Colorectal Cancer Patients

  2010cited by this paper
• Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data: An Alpe Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 014)

  2010cited by this paper
• The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis

  2010cited by this paper
• Activity of MMP-2 and MMP-9 in sera of breast cancer patients.

  2010cited by this paper
• Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?

  2010cited by this paper
• Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal Cancer

  2010cited by this paper
• Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients.

  2010cited by this paper
• Genetic polymorphisms in the MMP‐7 gene and breast cancer survival

  2009cited by this paper
• Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.

  2009cited by this paper
• Alternative splicing variant of vascular endothelial growth factor-A is a critical prognostic factor in non-small cell lung cancer.

  2009cited by this paper
• Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.

  2009cited by this paper
• Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics.

  2009cited by this paper
• Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting

  2009cited by this paper
• Matrix metalloproteinase proteomics: substrates, targets, and therapy.

  2009cited by this paper
• Salivary analysis of oral cancer biomarkers

  2009cited by this paper
• Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.

  2009cited by this paper
• Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

  2009cited by this paper
• Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.

  2009cited by this paper
• Clinical Significance of the Measurements of Serum Matrix Metalloproteinase-9 and Its Inhibitor (Tissue Inhibitor of Metalloproteinase-1) in Patients With Pancreatic Cancer: Metalloproteinase-9 as an Independent Prognostic Factor

  2009cited by this paper
• Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.

  2009cited by this paper
• Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease

  2009cited by this paper
• Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.

  2009cited by this paper
• Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas

  2009influential reference
• Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1

  2008cited by this paper
• Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer.

  2008cited by this paper
• Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis.

  2008cited by this paper
• CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer

  2008cited by this paper
• Tumor-derived Matrix Metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer

  2008cited by this paper
• Predictive value of MMP‐7 expression for response to chemotherapy and survival in patients with non‐small cell lung cancer

  2008cited by this paper
• Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database.

  2008cited by this paper
• Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy

  2008cited by this paper
• Plasma matrix metalloproteinase‐7 as a metastatic marker and survival predictor in patients with renal cell carcinomas

  2008cited by this paper
• Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species

  2008cited by this paper
• The regulation of matrix metalloproteinases and their inhibitors.

  2008cited by this paper
• Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities

  2008cited by this paper
• Cancer invasion and metastasis: changing views

  2008cited by this paper
• The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.

  2008cited by this paper
• Emerging roles of proteases in tumour suppression

  2007cited by this paper
• Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.

  2007cited by this paper
• Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.

  2007cited by this paper
• Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

  2007cited by this paper
• The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer

  2007cited by this paper
• MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.

  2007cited by this paper
• Stromelysin‐3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34

  2007cited by this paper
• The other side of MMPs: Protective roles in tumor progression

  2007cited by this paper
• Prognostic significance of matrix metalloproteinases‐1, ‐2, ‐7 and ‐13 and tissue inhibitors of metalloproteinases‐1, ‐2, ‐3 and ‐4 in colorectal cancer

  2007cited by this paper
• The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1‐MMP) and MMP‐9 according to their localization in invasive breast carcinoma

  2007cited by this paper
• Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine.

  2007cited by this paper
• Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention

  2007cited by this paper
• Study of matrix metalloproteinases and their inhibitors in breast cancer

  2007cited by this paper
• Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population

  2006cited by this paper
• Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

  2006cited by this paper
• Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.

  2006cited by this paper
• Structure and function of matrix metalloproteinases and TIMPs.

  2006cited by this paper
• Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer

  2006cited by this paper
• Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.

  2006cited by this paper
• Circulating MMP2 and MMP9 in breast cancer—Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories

  2006cited by this paper
• Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.

  2006cited by this paper
• Pericellular proteases in angiogenesis and vasculogenesis.

  2006cited by this paper
• Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.

  2006cited by this paper
• Matrix metalloproteinases: roles in cancer and metastasis.

  2006cited by this paper
• Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.

  2006cited by this paper
• Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.

  2006cited by this paper
• Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.

  2006cited by this paper
• Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.

  2006cited by this paper
• Tissue MMP-2/TIMP-2-complex are better prognostic factors than serum MMP-2, MMP-9 or TIMP-1 in Stage I–III lung carcinoma

  2006cited by this paper
• Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer

  2005cited by this paper
• Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.

  2005cited by this paper
• Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

  2005cited by this paper
• Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors.

  2005cited by this paper
• The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer Patients

  2005cited by this paper
• Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.

  2005cited by this paper
• Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors.

  2005cited by this paper
• Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent

  2005cited by this paper
• Role of Serum Vascular Endothelial Growth Factor in the Prediction of Angiogenesis and Prognosis for Non-small Cell Lung Cancer

  2004cited by this paper
• Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

  2004cited by this paper
• Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer

  2004cited by this paper
• Collagenase unwinds triple‐helical collagen prior to peptide bond hydrolysis

  2004cited by this paper
• Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis

  2004cited by this paper
• A Protective Role for Matrix Metalloproteinase-3 in Squamous Cell Carcinoma

  2004cited by this paper
• Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.

  2003cited by this paper

• High intra-tumoral and serum matrix metalloproteinase 9 levels are associated with reduced survival of patients with glioblastoma and brain metastases

  2026cites this paper
• Natural bioactive gallic acid shows potential anticancer effects by inhibiting the proliferation and invasiveness behavior in human embryonic carcinoma cells

  2025cites this paper
• Plasma matrix metalloproteinases 7 and 8 and tissue inhibitor of metalloproteinases 1 as prognostic biomarkers in colorectal cancer

  2025cites this paper
• Aptamer-Based Strategies for Colorectal Cancer Detection: Emerging Technologies and Future Directions

  2025cites this paper
• Exploring the link between Di-2-ethylhexyl phthalate (DEHP) exposure and muscle mass: A systematic investigation utilizing NHANES data analysis, network toxicology and molecular docking approaches.

  2025cites this paper
• Aptasensors in colorectal Cancer: Emerging tools for precision diagnostics.

  2025cites this paper
• Evidence for the Prognostic Value of CDH17 Expression in Colorectal Carcinoma

  2025cites this paper
• Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity

  2025cites this paper
• Syndecan-1 as a therapeutic target in squamous cell carcinoma: Current insights and future directions

  2024cites this paper
• Design and evaluation of an MMP-9-responsive hydrogel for vital pulp therapy.

  2024cites this paper
• A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways

  2024cites this paper
• MATRIX METALLOPROTEINASE MMP7 AS NEW PROGNOSTIC BIOMARKER FOR GASTRIC CANCER

  2024cites this paper
• Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions

  2024cites this paper
• Synthesis of Ti4+ modified COF-based polymer for efficient enrichment of phosphopeptides in colorectal cancer serum

  2024cites this paper
• Exploring Label-Free Imaging Techniques with Copper Sulfide Microspheres for Observing Breast Cancer Cells

  2024cites this paper
• Network pharmacology and experimental validation reveals the potential therapeutic effects of Polygonum cuspidatum against odontogenic keratocyst.

  2024cites this paper
• Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia

  2024cites this paper
• A review of matrix Metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy.

  2024cites this paper
• Matrix Metalloproteinases on Skin Photoaging

  2024cites this paper
• Syndecan-1 and E-Cadherin Expression in Canine Cutaneous Squamous Cell Carcinoma

  2024cites this paper
• E-Cadherin and its signaling pathways: A novel target of dietary components in modulating cell migration and proliferation

  2024cites this paper
• Polymer-drug and polymer-protein conjugated nanocarriers: Design, drug delivery, imaging, therapy, and clinical applications.

  2024cites this paper
• Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC)

  2024cites this paper
• Matrix metalloproteinase‐11 regulates inverted papilloma epithelial cell migration and invasion

  2024cites this paper
• Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells

  2024cites this paper
• Translationally Controlled Tumor Protein Enhances Angiogenesis in Ovarian Tumors by Activating Vascular Endothelial Growth Factor Receptor 2 Signaling

  2024cites this paper
• Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours—A Research Hypothesis

  2023cites this paper
• Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer

  2023cites this paper
• Research Progress on the Anti-Tumor Mechanism and Reversal of Multidrug Resistance of Zuojin Pill and its Main Components, Evodiamine and Berberine

  2023cites this paper
• Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes

  2023cites this paper
• Correlation of TIMP1-MMP2/MMP9 Gene Expression Axis Changes with Treatment Efficacy and Survival of NSCLC Patients

  2023cites this paper
• Quantification of MMP-2 and TIMP-1 expressions in breast cancer

  2023cites this paper
• Role of Leptin and Adiponectin in Carcinogenesis

  2023cites this paper
• MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH LARYNGEAL CANCER

  2023cites this paper
• Prognostic utility of TME-associated genes in pancreatic cancer

  2023cites this paper
• High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV

  2023cites this paper
• Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)

  2023cites this paper
• The Triple Crown: NO, CO, and H2S in cancer cell biology.

  2023cites this paper
• Matrine inhibits hepatocellular carcinoma cell malignancy through the circ_0013290/miR-139-5p/MMP16 pathway.

  2022cites this paper
• Effects of Propofol Versus Sevoflurane on Postoperative Breast Cancer Prognosis: A Narrative Review

  2022cites this paper
• IGFBP3 inhibits tumor growth and invasion of lung cancer cells and is associated with improved survival in lung cancer patients

  2022cites this paper
• A PD-L1 and VEGFR2 dual targeted peptide and its combination with irradiation for cancer immunotherapy.

  2022cites this paper
• Near-Infrared-Emissive AIE Bioconjugates: Recent Advances and Perspectives

  2022cites this paper
• Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors

  2022cites this paper
• Targeting Soluble Factors Involved in Inflammatory Cancer Microenvironment

  2022cites this paper
• Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology

  2022cites this paper
• Metformin as a Potential Treatment Option for Endometriosis

  2022cites this paper
• Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer

  2022cites this paper
• Genetic Modifications That Expand Oncolytic Virus Potency

  2022cites this paper
• Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression

  2022cites this paper
• Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins

  2022cites this paper
• Natural Plant Compounds: Does Caffeine, Dipotassium Glycyrrhizinate, Curcumin, and Euphol Play Roles as Antitumoral Compounds in Glioblastoma Cell Lines?

  2022cites this paper
• Glucosamine‐phosphate N‐acetyltransferase 1 and its DNA methylation can be biomarkers for the diagnosis and prognosis of lung cancer

  2022cites this paper
• LncRNA EWSAT1 Regulates the Tumorigenesis of NSCLC as a ceRNA by Modulating miR-330-5p/ITGA5 Axis

  2021cites this paper
• Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy

  2021cites this paper
• Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds

  2021cites this paper
• Recent progress in functional peptides designed for tumor-targeted imaging and therapy

  2021cites this paper
• Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro.

  2021cites this paper
• Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma

  2021cites this paper
• Electrochemical immunoplatform to assist in the diagnosis and classification of breast cancer through the determination of matrix-metalloproteinase-9.

  2021cites this paper
• Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma

  2021cites this paper
• Highway to Success—Developing Advanced Polymer Therapeutics

  2021cites this paper
• Qualitative and Quantitative Analysis of Tumor Cell Invasion Using Au Clusters

  2021cites this paper
• Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression

  2021cites this paper
• Oral Cancer Theranostic Application of FeAu Bimetallic Nanoparticles Conjugated with MMP-1 Antibody

  2021cites this paper
• MMP9 and CEBPα Genes as a New Prognostic Biomarker for Hepatocellular Carcinoma Caused by Infection with HCV-Genotype (4)

  2021cites this paper
• Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer

  2021cites this paper
• Berberine inhibited metastasis through miR-145/MMP16 axis in vitro

  2021cites this paper
• Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies

  2021cites this paper
• CMAR_A_338957 9305..9318

  2021cites this paper
• The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis

  2021cites this paper
• A Review on Engineered Magnetic Nanoparticles in Non-Small-Cell Lung Carcinoma Targeted Therapy.

  2021cites this paper
• Bioanalytical methods for circulating extracellular matrix-related proteins: new opportunities in cancer diagnosis

  2021influential citation
• Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy

  2021cites this paper
• PPARγ Agonists: Emergent Therapy in Endometriosis

  2021cites this paper
• Melatonin Induces Apoptosis and Modulates Cyclin Expression and MAPK Phosphorylation in Pancreatic Stellate Cells Subjected to Hypoxia

  2021cites this paper
• Targeting matrix metalloproteinase MMP3 greatly enhances oncolytic virus mediated tumor therapy

  2021cites this paper
• (Macro)molecular self-assembly for hydrogel drug delivery.

  2021cites this paper
• Recent advances in stimuli‐responsive theranostic systems with aggregation‐induced emission characteristics

  2021cites this paper
• Implications of microgravity-induced cell signaling alterations upon cancer cell growth, invasiveness, metastatic potential, and control by host immunity.

  2021cites this paper
• Matrix Metallopeptidase 3 Polymorphisms: Emerging genetic Markers in Human Breast Cancer Metastasis

  2020cites this paper
• Crosstalk among colon cancer-derived exosomes, fibroblast-derived exosomes, and macrophage phenotypes in colon cancer metastasis.

  2020cites this paper
• ASAP-SML: An antibody sequence analysis pipeline using statistical testing and machine learning

  2020cites this paper
• Molecular principles of metastasis: a hallmark of cancer revisited

  2020cites this paper
• Characteristics of Redox-Metabolism in Patients with Metastatic Colorectal Cancer: Clinical Significance

  2020cites this paper
• Role of Tissue Microenvironment in Recruiting Macrophages During Apoptosis-induced Proliferation

  2020cites this paper
• Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis

  2020cites this paper
• Metalloproteinases and their roles in human cancer

  2020cites this paper
• Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma

  2020cites this paper
• Silencing glioma-associated oncogene homolog 1 suppresses the migration and invasion of hepatocellular carcinoma in vitro

  2020cites this paper
• Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer

  2020cites this paper
• Matrix metalloproteinases in keratinocyte carcinomas

  2020cites this paper
• Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression

  2020cites this paper
• Enzyme-Responsive Peptide-Based AIE Bioprobes

  2020cites this paper
• Pancreatic stellate cells exhibit adaptation to oxidative stress evoked by hypoxia

  2020cites this paper
• Apatinib Inhibits the Invasion and Metastasis of Liver Cancer Cells by Downregulating MMP-Related Proteins via Regulation of the NF-κB Signaling Pathway

  2020cites this paper
• Basement membrane damage by ROS- and JNK-mediated Mmp2 activation drives macrophage recruitment to overgrown tissue

  2020cites this paper
• 6-Gingerol delays tumorigenesis in benzo[a]pyrene and dextran sulphate sodium-induced colorectal cancer in mice.

  2020cites this paper
• Diagnostic value of Doppler ultrasound parameters combined with MMP-11 in early breast cancer and benign breast diseases

  2020cites this paper
• Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics

  2020cites this paper